See every side of every news story
Published loading...Updated

$700 million biotech plant expected to bring 400 of jobs to N.C. town

  • Genentech revealed plans to invest $700 million in a new manufacturing plant in Holly Springs, North Carolina, which is expected to generate more than 400 jobs by 2032.
  • The investment follows Genentech's decision to expand operations to the East Coast to support its metabolic medicines portfolio amid growing demand.
  • The 700,000-square-foot facility will add 1,500 construction jobs and join Roche and Genentech's 13 other U.S. Manufacturing sites across eight states.
  • Governor Josh Stein expressed pride in Genentech’s decision to establish its inaugural East Coast manufacturing site in North Carolina, emphasizing the state’s robust biotech talent pool and the economic advantages this investment brings.
  • The initiative is projected to contribute more than $3 billion to the state's economic growth and create jobs with an average annual salary close to $120,000, further advancing Holly Springs' expanding biotechnology sector.
Insights by Ground AI
Does this summary seem wrong?

12 Articles

All
Left
1
Center
3
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 75% of the sources are Center
75% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Wral News broke the news in Raleigh, United States on Monday, May 12, 2025.
Sources are mostly out of (0)